19
Sun, May

moderna

    • The world's biggest COVID-19 vaccine test got underway July 27 with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc., and it's one of several candidates in the final stretch of the global vaccine race.

    Dr. Noubar Afeyan, co-founder and chairman of Moderna Therapeutics, said the biotech firm would become the first U.S. company to enter Phase III of a clinical trial for a potential coronavirus vaccine.

    • The one-dose option worked better in the U.S. — 72% effective against moderate to severe COVID-19 — compared with 66% in Latin America and 57% in South Africa, where a more contagious mutant virus is spreading.

    Johnson & Johnson asked U.S. regulators Thursday to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.

    • Currently, Pfizer has the only U.S. vaccine authorized for children 12 years and up, while Moderna is expecting an FDA ruling on its application in the coming days.

    Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.

    • The vaccines are not a panacea, however, as they will take months to roll out to a nation where the virus is running rampant and public health measures such as social distancing and mask wearing are being rejected by large parts of the population.

    The U.S. Food and Drug Administration (FDA) will “rapidly” work towards granting emergency approval of Moderna Inc’s COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.

AcyMailing: Could not load compat file for J4.3.1This module can not work without the AcyMailing Component